H2AB1
gene geneOn this page
Also known as H2A.B.2
Summary
H2AB1 (H2A.B variant histone 1, HGNC:22516) is a protein-coding gene on chromosome Xq28, encoding Histone H2A-Bbd type 1 (P0C5Y9). Atypical histone H2A which can replace conventional H2A in some nucleosomes and is associated with active transcription and mRNA processing.
Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene encodes a replication-independent histone that is a member of the histone H2A family. This gene is part of a region that is repeated three times on chromosome X, once in intron 22 of the F8 gene and twice closer to the Xq telomere. This record represents the most centromeric copy which is in intron 22 of the F8 gene.
Source: NCBI Gene 474382 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_001017990
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22516 |
| Approved symbol | H2AB1 |
| Name | H2A.B variant histone 1 |
| Location | Xq28 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | H2A.B.2 |
| Ensembl gene | ENSG00000274183 |
| Ensembl biotype | protein_coding |
| OMIM | 301037 |
| Entrez | 474382 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000620016
RefSeq mRNA: 1 — MANE Select: NM_001017990
NM_001017990
CCDS: CCDS35458
Canonical transcript exons
ENST00000620016 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003719914 | 154884972 | 154885558 |
Expression profiles
Bgee: expression breadth ubiquitous, 118 present calls, max score 96.98.
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 96.98 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 69.03 | gold quality |
| apex of heart | UBERON:0002098 | 63.94 | gold quality |
| right testis | UBERON:0004534 | 58.24 | gold quality |
| left testis | UBERON:0004533 | 53.76 | gold quality |
| cortical plate | UBERON:0005343 | 53.21 | gold quality |
| testis | UBERON:0000473 | 53.02 | gold quality |
| ganglionic eminence | UBERON:0004023 | 50.54 | gold quality |
| blood | UBERON:0000178 | 46.68 | gold quality |
| duodenum | UBERON:0002114 | 44.93 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 44.02 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 43.97 | gold quality |
| bone marrow | UBERON:0002371 | 42.77 | gold quality |
| cortex of kidney | UBERON:0001225 | 42.14 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 42.03 | gold quality |
| right lobe of liver | UBERON:0001114 | 39.66 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 39.46 | gold quality |
| lymph node | UBERON:0000029 | 38.64 | gold quality |
| tonsil | UBERON:0002372 | 38.63 | silver quality |
| liver | UBERON:0002107 | 37.92 | gold quality |
| metanephros cortex | UBERON:0010533 | 37.74 | gold quality |
| muscle tissue | UBERON:0002385 | 37.24 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| muscle of leg | UBERON:0001383 | 36.98 | gold quality |
| left uterine tube | UBERON:0001303 | 36.93 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.84 | silver quality |
| gastrocnemius | UBERON:0001388 | 36.82 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| vermiform appendix | UBERON:0001154 | 35.46 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.12 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
23 targeting H2AB1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-3151-5P | 99.86 | 63.83 | 1069 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-3136-3P | 99.57 | 66.59 | 781 |
| HSA-MIR-7155-3P | 99.57 | 66.48 | 794 |
| HSA-MIR-4472 | 99.56 | 66.08 | 1478 |
| HSA-MIR-363-5P | 99.46 | 64.51 | 1015 |
| HSA-MIR-128-1-5P | 99.33 | 60.46 | 332 |
| HSA-MIR-128-2-5P | 99.33 | 60.83 | 311 |
| HSA-MIR-7109-5P | 99.18 | 66.13 | 1057 |
| HSA-MIR-491-5P | 99.13 | 65.98 | 1468 |
| HSA-MIR-661 | 99.09 | 65.94 | 2062 |
| HSA-MIR-4260 | 98.78 | 65.37 | 848 |
| HSA-MIR-1227-5P | 98.65 | 65.32 | 1549 |
| HSA-MIR-6887-5P | 98.56 | 68.49 | 1295 |
| HSA-MIR-6795-5P | 98.52 | 68.51 | 1277 |
| HSA-MIR-6742-5P | 96.32 | 64.01 | 869 |
| HSA-MIR-6796-5P | 95.37 | 66.08 | 1120 |
| HSA-MIR-2861 | 95.24 | 65.47 | 1056 |
| HSA-MIR-6781-5P | 94.61 | 59.49 | 155 |
| HSA-MIR-492 | 94.02 | 64.46 | 413 |
Literature-anchored findings (GeneRIF, showing 2)
- Structural basis of nucleosome dynamics modulation by histone variants H2A.B and H2A.Z.2.2. (PMID:33073403)
- H2A.B is a cancer/testis factor involved in the activation of ribosome biogenesis in Hodgkin lymphoma. (PMID:34350706)
Cross-species orthologs
24 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | H2ab1 | ENSMUSG00000067441 |
| mus_musculus | H2ab2 | ENSMUSG00000082482 |
| mus_musculus | H2ab3 | ENSMUSG00000083616 |
| rattus_norvegicus | H2ab3 | ENSRNOG00000029736 |
| drosophila_melanogaster | His2A:CG31618 | FBGN0051618 |
| drosophila_melanogaster | His2A:CG33808 | FBGN0053808 |
| drosophila_melanogaster | His2A:CG33814 | FBGN0053814 |
| drosophila_melanogaster | His2A:CG33817 | FBGN0053817 |
| drosophila_melanogaster | His2A:CG33820 | FBGN0053820 |
| drosophila_melanogaster | His2A:CG33823 | FBGN0053823 |
| drosophila_melanogaster | His2A:CG33826 | FBGN0053826 |
| drosophila_melanogaster | His2A:CG33829 | FBGN0053829 |
| drosophila_melanogaster | His2A:CG33832 | FBGN0053832 |
| drosophila_melanogaster | His2A:CG33835 | FBGN0053835 |
| drosophila_melanogaster | His2A:CG33838 | FBGN0053838 |
| drosophila_melanogaster | His2A:CG33841 | FBGN0053841 |
| drosophila_melanogaster | His2A:CG33844 | FBGN0053844 |
| drosophila_melanogaster | His2A:CG33847 | FBGN0053847 |
| drosophila_melanogaster | His2A:CG33850 | FBGN0053850 |
| drosophila_melanogaster | His2A:CG33853 | FBGN0053853 |
| drosophila_melanogaster | His2A:CG33856 | FBGN0053856 |
| drosophila_melanogaster | His2A:CG33859 | FBGN0053859 |
| drosophila_melanogaster | His2A:CG33862 | FBGN0053862 |
| drosophila_melanogaster | His2A:CG33865 | FBGN0053865 |
Paralogs (27): MACROH2A2 (ENSG00000099284), H2AZ2 (ENSG00000105968), MACROH2A1 (ENSG00000113648), H2AZ1 (ENSG00000164032), H2AC1 (ENSG00000164508), H2AC6 (ENSG00000180573), H2AC25 (ENSG00000181218), H2AC20 (ENSG00000184260), H2AC21 (ENSG00000184270), H2AX (ENSG00000188486), H2AC13 (ENSG00000196747), H2AC11 (ENSG00000196787), H2AC7 (ENSG00000196866), H2AL3 (ENSG00000229674), H2AJ (ENSG00000246705), H2AL1Q (ENSG00000249467), H2AC12 (ENSG00000274997), H2AC15 (ENSG00000275221), H2AC14 (ENSG00000276368), H2AC16 (ENSG00000276903), H2AC8 (ENSG00000277075), H2AB3 (ENSG00000277745), H2AB2 (ENSG00000277858), H2AC4 (ENSG00000278463), H2AC17 (ENSG00000278677), H2AC18 (ENSG00000288825), H2AC19 (ENSG00000288859)
Protein
Protein identifiers
Histone H2A-Bbd type 1 — P0C5Y9 (reviewed: P0C5Y9)
Alternative names: H2A Barr body-deficient
All UniProt accessions (1): P0C5Y9
UniProt curated annotations — full annotation on UniProt →
Function. Atypical histone H2A which can replace conventional H2A in some nucleosomes and is associated with active transcription and mRNA processing. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. Nucleosomes containing this histone are less rigid and organize less DNA than canonical nucleosomes in vivo. They are enriched in actively transcribed genes and associate with the elongating form of RNA polymerase. They associate with spliceosome components and are required for mRNA splicing.
Subunit / interactions. The nucleosome is a histone octamer containing two molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and two H2A-H2B heterodimers. May be incorporated into a proportion of nucleosomes, replacing one or more H2A molecules.
Subcellular location. Nucleus. Chromosome.
Tissue specificity. Present in mature sperm.
Domain organisation. The docking domain is responsible for the weaker heterodimerization with H2B.
Miscellaneous. In contrast to other H2A histones, it does not contain the conserved residues that are the target of post-translational modifications.
Similarity. Belongs to the histone H2A family.
RefSeq proteins (1): NP_001017990* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002119 | Histone_H2A | Family |
| IPR009072 | Histone-fold | Homologous_superfamily |
UniProt features (4 total): region of interest 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0C5Y9-F1 | 87.90 | 0.76 |
Function
Pathways and Gene Ontology
Reactome pathways
47 pathways
| ID | Pathway |
|---|---|
| R-HSA-110328 | Recognition and association of DNA glycosylase with site containing an affected pyrimidine |
| R-HSA-110329 | Cleavage of the damaged pyrimidine |
| R-HSA-110330 | Recognition and association of DNA glycosylase with site containing an affected purine |
| R-HSA-110331 | Cleavage of the damaged purine |
| R-HSA-1221632 | Meiotic synapsis |
| R-HSA-171306 | Packaging Of Telomere Ends |
| R-HSA-1912408 | Pre-NOTCH Transcription and Translation |
| R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex |
| R-HSA-212300 | PRC2 methylates histones and DNA |
| R-HSA-2299718 | Condensation of Prophase Chromosomes |
| R-HSA-2559580 | Oxidative Stress Induced Senescence |
| R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) |
| R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence |
| R-HSA-3214858 | RMTs methylate histone arginines |
| R-HSA-427359 | SIRT1 negatively regulates rRNA expression |
| R-HSA-427389 | ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression |
| R-HSA-427413 | NoRC negatively regulates rRNA expression |
| R-HSA-5250924 | B-WICH complex positively regulates rRNA expression |
| R-HSA-5334118 | DNA methylation |
| R-HSA-5578749 | Transcriptional regulation by small RNAs |
| R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogenesis |
| R-HSA-5625886 | Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 |
| R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere |
| R-HSA-68616 | Assembly of the ORC complex at the origin of replication |
| R-HSA-73728 | RNA Polymerase I Promoter Opening |
| R-HSA-73772 | RNA Polymerase I Promoter Escape |
| R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function |
| R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs |
| R-HSA-9018519 | Estrogen-dependent gene expression |
| R-HSA-912446 | Meiotic recombination |
MSigDB gene sets: 111 (showing top):
REACTOME_MEIOTIC_RECOMBINATION, REACTOME_DNA_REPLICATION, REACTOME_SIGNALING_BY_NOTCH, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, REACTOME_MEIOTIC_SYNAPSIS, REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS, GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC, GOBP_PROTEIN_DNA_COMPLEX_ORGANIZATION, REACTOME_DNA_REPAIR, GOBP_CHROMATIN_REMODELING, GOBP_HETEROCHROMATIN_ORGANIZATION, GOBP_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, GOCC_PROTEIN_DNA_COMPLEX, REACTOME_REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY, GOCC_EUCHROMATIN
GO Biological Process (3): nucleosome assembly (GO:0006334), mRNA processing (GO:0006397), heterochromatin formation (GO:0031507)
GO Molecular Function (3): DNA binding (GO:0003677), structural constituent of chromatin (GO:0030527), protein heterodimerization activity (GO:0046982)
GO Cellular Component (4): nucleosome (GO:0000786), euchromatin (GO:0000791), nucleus (GO:0005634), chromosome (GO:0005694)
Reactome top-level categories
Rollup of top-13 pathways:
| Category | Pathways |
|---|---|
| Cellular Senescence | 3 |
| Depyrimidination | 2 |
| Depurination | 2 |
| Epigenetic regulation of gene expression | 2 |
| Negative epigenetic regulation of rRNA expression | 2 |
| Positive epigenetic regulation of rRNA expression | 2 |
| Meiosis | 1 |
| Telomere Maintenance | 1 |
| Pre-NOTCH Expression and Processing | 1 |
| TCF dependent signaling in response to WNT | 1 |
| Mitotic Prophase | 1 |
| Chromatin modifying enzymes | 1 |
| Gene Silencing by RNA | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| chromatin | 3 |
| chromatin organization | 1 |
| nucleosome organization | 1 |
| protein-DNA complex assembly | 1 |
| RNA processing | 1 |
| mRNA metabolic process | 1 |
| cellular component assembly | 1 |
| heterochromatin boundary formation | 1 |
| negative regulation of gene expression, epigenetic | 1 |
| heterochromatin organization | 1 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| protein dimerization activity | 1 |
| protein-DNA complex | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
1320 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| H2AB1 | H2BC21 | Q16778 | 708 |
| H2AB1 | H3Y1 | P0DPK2 | 606 |
| H2AB1 | H3Y2 | P0DPK5 | 590 |
| H2AB1 | CENPA | P49450 | 561 |
| H2AB1 | CD74 | P04233 | 528 |
| H2AB1 | H1-0 | P07305 | 481 |
| H2AB1 | IL33 | O95760 | 460 |
| H2AB1 | H2BC1 | Q96A08 | 451 |
| H2AB1 | H1-7 | Q75WM6 | 415 |
| H2AB1 | H2AP | O75409 | 373 |
| H2AB1 | H1-6 | P22492 | 370 |
| H2AB1 | H1-8 | Q8IZA3 | 367 |
| H2AB1 | H3C1 | P02295 | 361 |
| H2AB1 | H3-4 | Q16695 | 346 |
| H2AB1 | H4C7 | Q99525 | 339 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| H2AB1 | UBB | psi-mi:“MI:0914”(association) | 0.350 |
| H2AB1 | NRDC | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (24): CHCHD2 (Affinity Capture-MS), TEX10 (Affinity Capture-MS), H2AFB1 (Affinity Capture-MS), UBB (Affinity Capture-MS), NOL9 (Affinity Capture-MS), RAB15 (Affinity Capture-MS), SENP3 (Affinity Capture-MS), H2AFB1 (Affinity Capture-MS), C1QBP (Affinity Capture-MS), MDM2 (Affinity Capture-MS), BAG1 (Affinity Capture-MS), PELP1 (Affinity Capture-MS), CYBA (Affinity Capture-MS), NRD1 (Affinity Capture-MS), MDC1 (Affinity Capture-MS)
ESM2 similar proteins: A0A1W2PP81, A0A1W2PPE2, A0A1W2PPH5, A0A1W2PPL8, A0A1W2PR64, A0A1W2PRV1, A0A3B3IU63, A4QVR2, A5DQL2, A9UMV8, F4HR03, O35216, P06898, P0C1H6, P0C5Y9, P0C5Z0, P0DW11, P0DW12, P0DW13, P0DW14, P0DW85, P35061, P48003, P49450, Q00728, Q3SZB8, Q3ZBX9, Q4IMD1, Q5M8Q2, Q5TKR9, Q64522, Q64598, Q7Z2G1, Q803H4, Q873G4, Q8BRB7, Q8BZ21, Q8CGP5, Q8IUE6, Q8R1M2
Diamond homologs: A0A3B3IU63, A1A4R1, A2WQG7, A5DBG4, A5DJJ2, A5DXS8, A9UMV8, C0HKE1, C0HKE2, C0HKE3, C0HKE4, C0HKE5, C0HKE6, C0HKE7, C0HKE8, C0HKE9, P02262, P02263, P02264, P02269, P02270, P02273, P02274, P02276, P02277, P04908, P06897, P07793, P09588, P0C0S8, P0C0S9, P0C169, P0C170, P0C5Y9, P0C5Z0, P0CC09, P0CN98, P0CN99, P13630, P13912
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SLBP | “up-regulates quantity by expression” | H2AB1 | “translation regulation” |
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
138 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:154885058:G:GT | donor_gain | 0.9200 |
| X:154885061:G:GT | donor_gain | 0.9200 |
| X:154885224:GTTAT:G | donor_gain | 0.8700 |
| X:154885225:TTATT:T | donor_gain | 0.8700 |
| X:154885228:T:TG | donor_gain | 0.8100 |
| X:154885226:TATTG:T | donor_gain | 0.7100 |
| X:154885227:ATTGA:A | donor_gain | 0.7100 |
| X:154885275:C:T | acceptor_gain | 0.7100 |
| X:154885142:A:AG | acceptor_gain | 0.7000 |
| X:154885143:G:GG | acceptor_gain | 0.7000 |
| X:154885087:C:CG | donor_gain | 0.6800 |
| X:154885153:T:TA | donor_gain | 0.6800 |
| X:154885154:G:GA | donor_gain | 0.6800 |
| X:154885275:C:CT | acceptor_gain | 0.6800 |
| X:154885337:GCTAC:G | donor_gain | 0.6400 |
| X:154885249:TCCCG:T | donor_gain | 0.6300 |
| X:154885187:GCGCC:G | donor_gain | 0.6200 |
| X:154885170:G:T | donor_gain | 0.6100 |
| X:154885232:G:GG | donor_gain | 0.6100 |
| X:154884986:C:G | donor_gain | 0.5900 |
| X:154885040:AACGC:A | donor_gain | 0.5900 |
| X:154885169:G:GT | donor_gain | 0.5900 |
| X:154885231:A:AG | donor_gain | 0.5900 |
| X:154885143:GTGA:G | acceptor_gain | 0.5600 |
| X:154885148:C:T | donor_gain | 0.5500 |
| X:154885189:GCC:G | donor_gain | 0.5500 |
| X:154885322:G:GA | donor_gain | 0.5500 |
| X:154884985:ACT:A | donor_gain | 0.5300 |
| X:154885142:AGT:A | acceptor_gain | 0.5300 |
| X:154885143:GTG:G | acceptor_gain | 0.5300 |
AlphaMissense
721 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:154885137:T:C | F30L | 0.918 |
| X:154885139:T:A | F30L | 0.918 |
| X:154885139:T:G | F30L | 0.918 |
| X:154885353:T:C | F102L | 0.767 |
| X:154885355:C:A | F102L | 0.767 |
| X:154885355:C:G | F102L | 0.767 |
| X:154885221:G:C | A58P | 0.592 |
| X:154885194:A:C | S49R | 0.581 |
| X:154885196:T:A | S49R | 0.581 |
| X:154885196:T:G | S49R | 0.581 |
| X:154885297:T:C | I83T | 0.581 |
dbSNP variants (sampled 300 via entrez): RS113683431 (X:154886026 G>C), RS1156675377 (X:154885705 G>A), RS1161854920 (X:154884962 G>T), RS1163080636 (X:154885354 T>G), RS1166099089 (X:154885159 G>A), RS1166324509 (X:154885500 A>T), RS1166720558 (X:154885829 G>A), RS1167468518 (X:154885964 CGGGGGGGGG>C,CGG,CGGGGG,CGGGGGG,CGGGGGGG,CGGGGGGGG,CGGGGGGGGGG,CGGGGGGGGGGG), RS1171881100 (X:154885629 G>C), RS1175661281 (X:154885555 G>A), RS1179806735 (X:154885650 G>A), RS1183187239 (X:154885718 G>A,C), RS1184863941 (X:154885983 C>A), RS1187041935 (X:154885182 G>A), RS1188443344 (X:154885862 G>A,C)
Disease associations
OMIM: gene MIM:301037 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.